What we do
At Polpharma Biologics we are focused on developing the next generation of biosimilars to improve patient access and reduce health care costs.
Our pipeline is continuously growing and our late stage products are nearing the market. We look to partner with some of the worlds largest biotech so our biosimilars can reach those that need them.
6+
biologics in the pipeline
3
Development & manufacturing facilities
Bioreactor production capacity
People employed
Polish scientists returned from abroad
We care
our driving value for what we do
Our science and technology
We have some of the most advanced development and manufacturing facilities in Europe staffed by highly skilled and experienced scientists from across the globe.
Our cell line development, process development and analytical development team set the foundation for all our programs. They are the first step in creating our pipeline.
We have state of the art manufacturing facilities for both mammalian and microbial manufacturing for clinical for preclinical, clinical and commercial supply, including fill and finish.
Our clinical operations group manages pre-clinical and clinical trials, a lengthy process but critical to ensuring our biosimilars are safe and effective for the patients that need them most.
